Enzalutamide, a potent anti-cancer medication, has become a cornerstone in the treatment of prostate cancer. As a targeted therapy, it has revolutionized the way healthcare providers manage advanced stages of prostate cancer, particularly castration-resistant prostate cancer (CRPC). However, despite its efficacy, Enzalutamide comes with a hefty pri